Showing results (11-20 of 48) with videos related to
Sort By:
Pageof 5
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 21, 2026
Prevalence and characteristics of persistent taste and smell dysfunction after immune checkpoint inhibitor therapy for cancerJip M van Elst, Corine M Buffinga, Henk S Brand, et al.Fertility and Sterility|April 29, 2008
Semen quality in men with disseminated testicular cancer: relation with human chorionic gonadotropin beta-subunit and pituitary gonadal hormonesDaphne de Bruin, Igle J de Jong, Eugène G J M Arts, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 10, 2008
Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancerEsther C de Haas, Nynke Zwart, Coby Meijer, et al.Endocrinology, Diabetes & Metabolism Case Reports|October 21, 2021
An aggressive poorly differentiated plurihormonal Pit-1-positive adenomaMark R Postma, Jos M A Kuijlen, Astrid G W Korsten, et al.Urologic Oncology|December 5, 2023
Change in telomere length and cardiovascular risk factors in testicular cancer survivorsEllen L D Volders, Coby Meijer, Lotte S Steeneken, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2023
Cardiovascular Disease in Testicular Cancer Survivors: Identification of Risk Factors and Impact on Quality of LifeSjoukje Lubberts, Harmke J Groot, Ronald de Wit, et al.Clinical Neuropathology|May 16, 2022
An aggressive lactotroph pituitary tumor in a young male: A pituitary carcinoma without metastasisFriederike E Roelandt-Schumann, Rob A Vergeer, Astrid G W Korsten-Meijer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Long-term risk of cardiovascular disease in 5-year survivors of testicular cancerAlexandra W van den Belt-Dusebout, Janine Nuver, Ronald de Wit, et al.Journal for Immunotherapy of Cancer|March 28, 2025
Quality of life, neurocognitive functioning, psychological issues, sexuality and comorbidity more than 2 years after commencing immune checkpoint inhibitor treatmentWellington Candido, Annemarie Cecile Eggen, Mathilde Jalving, et al.Pharmacogenetics and Genomics|May 19, 2005
Genetic variation in the bleomycin hydrolase gene and bleomycin-induced pulmonary toxicity in germ cell cancer patientsJanine Nuver, Martijn F Lutke Holzik, Martine van Zweeden, et al.Pageof 5